Gilbert Lynn Marks - 19 Jun 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANTX	Stock Option (Right to Buy)	Award	$0	+64,503		$0.000000	64,503	19 Jun 2024	Common Stock	64,503	$2.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option shares shall vest on the earlier of (a) the one-year anniversary of June 19, 2024 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date.

Exhibits: Power of Attorney